- ￥1800 - 17280
- AntibodySystem
- France
- EVV03301
- 2025年12月06日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Recombinant Influenza A virus (H3N2) NP/Nucleoprotein Protein, C-His
- 供应商：
武汉益普生物科技有限公司
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1800.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥2880.0 |
| 规格： | 1mg | 产品价格： | ￥17280.0 |
| 产品名 | Recombinant Influenza A virus (H3N2) NP/Nucleoprotein Protein, C-His |
| 货号 | EVV03301 |
| 别名 | Nucleoprotein, Nucleocapsid protein, Protein N, NP |
| 表达系统 | Mammalian cells |
| Accession号 | P16982 |
| 种属 | Influenza A virus (strain A/Hong Kong/5/1983 H3N2) |
| 蛋白长度 | Met1-Asn498 |
| 预测分子量 | 61.62 kDa |
| 性质 | Recombinant |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 应用 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| 状态 | Lyophilized |
| 保存溶液 | Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 运输 | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 说明 | For research use only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Influenza A Virus Molecular Virology Techniques
Molecular biological techniques for genomic analysis and for creation of recombinant viruses are critical tools in our efforts to understand and combat influenza A viruses. These molecular virology approaches are used in diagnostics, basic
PCR for the Detection of Influenza Viruses in Clinical Material
Influenza viruses are segmented, negative-stranded RNA viruses belonging to the family Orthomyxoviridae . They are classified into influenza A, B, and C on the basis of different epitopes on the nucleoprotein (NP) and matrix proteins (M
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
技术资料暂无技术资料 索取技术资料
